The Georgetown University Medical Center (GUMC), in conjunction with the Lombardi Cancer Center (LCC) and the Institute for Molecular and Human Genetics. This application shall serve as the formal request for NCRR funding to support the complete renovations of approximately 3,500 square feet of wet laboratory space on the first floor on the Medical School/Dental School (Med/Dent). GUMC offers its students and researchers a strong program in clinical and translational genetics. The existing resources at LCC and IMHG provide a strong base on which to expand a program in fundamental genetics research, based on research initiatives and interests, at the GUMC. The LCC is heavily funded by peer-reviewed agencies, and works with its established Internal and External Scientific Advisory Committees. In addition, the LCC and IMHG offer a protected environment in which to complete state-of-the-art research, supported by outstanding shared resources, for which space and funding are overseen by the Director, Dr. Marc Lippman and his advisory committees. As Director of the LCC, Acting Director of the IMHG, and Senior Research Operating Officer of GUMC, Dr. Lippman is unique placed to ensure that the research to be conducted in the renovated space is properly established and overseen as the program continues to develop and expand. Furthermore, he is committed to the long-term goals of the program, which will allow GUMC to be more competitive in recruiting and maintaining outstanding young researchers. This will result in GUMC's ability to expand and improve upon existing NIH-funded research projects, and in better training opportunities for its students and fellows. We are requesting funding for renovations which will allow three outstanding young investigators, who have already demonstrated their future potential, to expand into state-of-the-art genetics laboratories. One investigator will be relocated from a currently overcrowded facility in the hospital, to the renovated space which will serve as centralized space for basic genetics research. Two other investigators will move from temporary space provided by LCC. One additional investigator will be recruited to pursue his or her career in basic genetics research at GUMC.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Research Facilities Construction Grant (C06)
Project #
1C06RR014567-01
Application #
6044151
Study Section
Scientific and Technical Review Board on Biomedical and Behavioral Research Facilities (STRB)
Program Officer
Mccullough, Willie
Project Start
1999-09-30
Project End
2003-12-31
Budget Start
1999-09-30
Budget End
2003-12-31
Support Year
1
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Georgetown University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
049515844
City
Washington
State
DC
Country
United States
Zip Code
20057
Kim, Sang-Soo; Rait, Antonina; Garrido-Sanabria, Emilio R et al. (2018) Nanotherapeutics for Gene Modulation that Prevents Apoptosis in the Brain and Fatal Neuroinflammation. Mol Ther 26:84-94
AlHossiny, Midrar; Luo, Linlin; Frazier, William R et al. (2016) Ly6E/K Signaling to TGF? Promotes Breast Cancer Progression, Immune Escape, and Drug Resistance. Cancer Res 76:3376-86
Kim, Sang-Soo; Pirollo, Kathleen F; Chang, Esther H (2015) Isolation and Culturing of Glioma Cancer Stem Cells. Curr Protoc Cell Biol 67:23.10.1-10
Kim, Sang-Soo; Rait, Antonina; Kim, Eric et al. (2015) A tumor-targeting p53 nanodelivery system limits chemoresistance to temozolomide prolonging survival in a mouse model of glioblastoma multiforme. Nanomedicine 11:301-11
Kim, Sang-Soo; Rait, Antonina; Kim, Eric et al. (2015) Encapsulation of temozolomide in a tumor-targeting nanocomplex enhances anti-cancer efficacy and reduces toxicity in a mouse model of glioblastoma. Cancer Lett 369:250-8
Kim, Sang-Soo; Rait, Antonina; Rubab, Farwah et al. (2014) The clinical potential of targeted nanomedicine: delivering to cancer stem-like cells. Mol Ther 22:278-291
Kim, Sang-Soo; Rait, Antonina; Kim, Eric et al. (2014) A nanoparticle carrying the p53 gene targets tumors including cancer stem cells, sensitizes glioblastoma to chemotherapy and improves survival. ACS Nano 8:5494-514
Upadhyay, Geeta; Yin, Yuzhi; Yuan, Hongyan et al. (2011) Stem cell antigen-1 enhances tumorigenicity by disruption of growth differentiation factor-10 (GDF10)-dependent TGF-beta signaling. Proc Natl Acad Sci U S A 108:7820-5
Pollock, Claire B; Rodriguez, Olga; Martin, Philip L et al. (2010) Induction of metastatic gastric cancer by peroxisome proliferator-activated receptor? activation. PPAR Res 2010:571783
Yin, Yuzhi; Yuan, Hongyan; Zeng, Xiao et al. (2009) Inhibition of peroxisome proliferator-activated receptor gamma increases estrogen receptor-dependent tumor specification. Cancer Res 69:687-94

Showing the most recent 10 out of 20 publications